Jama, Kimhar S.
HRN: 22-28-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/10/2022
12/16/2022
IV
4.5g
Q6H
CAP-MR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes